Aldosterone antagonists for preventing the progression of chronic kidney disease

Aldosterone antagonists for preventing the progression of chronic kidney disease

Item
http://www.wikidata.org/entity/Q24239909
Direct renin inhibitors for preventing the progression of diabetic kidney diseaseVitamin B and/or its derivatives for diabetic kidney diseaseAldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to comThe past, present and future of renin-angiotensin aldosterone system inhibitionRenin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusRandomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and AnemiaAudit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results.Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?Do variations in allocation concealment methods influence the effects found in intervention reviews?Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?The effect of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies.Role of 11beta-hydroxysteroid dehydrogenase 2 renal activity in potassium homeostasis in rats with chronic renal failure.Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone - results from first-in-man and relative bioavailability studies.Lower Renal Function Is Associated With Derangement of 11-β Hydroxysteroid Dehydrogenase in Type 2 Diabetes.
P2860

Aldosterone antagonists for preventing the progression of chronic kidney disease

Item
http://www.wikidata.org/entity/Q24239909
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Aldosterone antagonists for preventing the progression of chronic kidney disease
@ast
Aldosterone antagonists for preventing the progression of chronic kidney disease
@en
Aldosterone antagonists for preventing the progression of chronic kidney disease
@en-gb
Aldosterone antagonists for preventing the progression of chronic kidney disease
@nl
type
label
Aldosterone antagonists for preventing the progression of chronic kidney disease
@ast
Aldosterone antagonists for preventing the progression of chronic kidney disease
@en
Aldosterone antagonists for preventing the progression of chronic kidney disease
@en-gb
Aldosterone antagonists for preventing the progression of chronic kidney disease
@nl
prefLabel
Aldosterone antagonists for preventing the progression of chronic kidney disease
@ast
Aldosterone antagonists for preventing the progression of chronic kidney disease
@en
Aldosterone antagonists for preventing the progression of chronic kidney disease
@en-gb
Aldosterone antagonists for preventing the progression of chronic kidney disease
@nl
P1433
P1476
P2093
P2860
P31
P356
P577
P698
P356
P1433
P1476
Aldosterone antagonists for preventing the progression of chronic kidney disease
@en
P2093
P2860
P31
P356
10.1002/14651858.CD007004.PUB2
P577
P698